<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00133718</url>
  </required_header>
  <id_info>
    <org_study_id>ABCD-study</org_study_id>
    <nct_id>NCT00133718</nct_id>
  </id_info>
  <brief_title>A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control</brief_title>
  <official_title>Asker and Baerum Cardiovascular Diabetes Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asker &amp; Baerum Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rikshospitalet University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Aker</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Asker &amp; Baerum Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of this study are:

        -  to investigate the extent of cardiovascular complications in a representative cohort
           (n=135) of adult patients with type 2 diabetes;

        -  to examine if modern non-invasive assessment can replace invasive assessment;

        -  to determine the effects of a 6 month lifestyle interventional program on weight,
           glycemic control and lipids in 60 patients;

        -  to determine the effect of a 2-year prospective, randomised multi-interventional program
           (n=120) on cardiovascular risk, anthropometric measures and glycometabolic control; and

        -  to investigate inflammatory markers in this setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As cardiovascular disease often is silent in type 2 diabetic patients, ways of detecting this
      early is of potential benefit, as is probably an aggressive treatment regimen trying to
      achieve goals for factors such as blood pressure, glycemic control, lipids, smoking, physical
      activity and weight.

      This study compares traditional non-invasive tests such as stress-ecg, modern non-invasive
      tests such as holter-analysis, modern ECG analysis, stress-ecco cardiography and tissue
      Doppler against the gold standard today for assessing coronary artery disease, coronary
      angiography, in patients with type 2 diabetes and at least one cv-risk factor (i.e smoking,
      premature familial coronary artery disease (CAD)), hypertension) irrespective of symptoms or
      signs of CAD.

      The participants are included in a randomized-control trial for 2 years where one arm
      receives standard treatment and one receives treatment after a multi-interventional program.

      End-points include: glycemic control, lipid control, weight control, blood pressure control,
      and effects on inflammatory parameters.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2002</start_date>
  <completion_date type="Actual">May 29, 2012</completion_date>
  <primary_completion_date type="Actual">April 2006</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Patients were randomized to intensive care of standard care, outcomes were assessed by experts who where unaware of group allocation</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in 10-year absolute CHD risk</measure>
    <time_frame>2-year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effects on cardiovascular events</measure>
    <time_frame>5-year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects on hospitalisations</measure>
    <time_frame>5-year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects on CV risk markers (HbA1c, lipids, blood pressure, inflammation, etc)</measure>
    <time_frame>2 years and 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects on health related quality of life</measure>
    <time_frame>2 years and 5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Structured multi intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Structured multi intervention to reach predefined glycemic and blood pressure goals as well as activity and weight goal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard care with or without structured care according to national guidelines</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Combined lifestyle intervention and optimisation of pharmacological treatment</intervention_name>
    <description>6 months non-pharmacological treatment, 18 months with polypharmacy for glucose control (metformin, repaglinide/glimepiride, pioglitazone or insulin)
standard care</description>
    <arm_group_label>Structured multi intervention</arm_group_label>
    <arm_group_label>Standard of care</arm_group_label>
    <other_name>Combination of drugs (predefined) to reach treatment targets</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes

          -  Ages 18-75 years

          -  Men and women

          -  At least one cardiovascular risk factor (i.e hypertension, dyslipidemia,
             smoking/formerly smoker, premature familial coronary artery disease [CAD],
             microalbuminuria)

          -  Written informed consent given

        Exclusion Criteria:

          -  Unwillingness

          -  Age &lt; 18 or &gt; 75 years

          -  Unstable cardiovascular condition

          -  Unstable medical condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Odd E Johansen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asker and Baerum Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asker and Baerum Hospital, Medical Department</name>
      <address>
        <city>RUD</city>
        <zip>1309</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Ofstad AP, Johansen OE, Gullestad L, Birkeland KI, Orvik E, Fagerland MW, Urheim S, Aakhus S. Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi-intervention in type 2 diabetes: the randomized controlled Asker and Bærum Cardiovascular Diabetes (ABCD) study. Am Heart J. 2014 Sep;168(3):280-288.e2. doi: 10.1016/j.ahj.2014.03.026. Epub 2014 Jun 9.</citation>
    <PMID>25173538</PMID>
  </reference>
  <reference>
    <citation>Ulimoen GR, Ofstad AP, Endresen K, Gullestad L, Johansen OE, Borthne A. Low-dose CT coronary angiography for assessment of coronary artery disease in patients with type 2 diabetes--a cross-sectional study. BMC Cardiovasc Disord. 2015 Nov 14;15:147. doi: 10.1186/s12872-015-0143-9.</citation>
    <PMID>26573616</PMID>
  </reference>
  <reference>
    <citation>Johansen OE, Bjurö T, Endresen K, Blaasaas KG, Birkeland K, Aakhus S, Gullestad L. Heart rate adjustments and analysis of recovery patterns of ST-segment depression in type 2 diabetes. Int J Cardiol. 2008 Jun 23;127(1):129-32. Epub 2007 May 25.</citation>
    <PMID>17532067</PMID>
  </reference>
  <reference>
    <citation>Johansen OE, Birkeland KI, Orvik E, Flesland Ø, Wergeland R, Ueland T, Smith C, Endresen K, Aukrust P, Gullestad L. Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects. Scand J Clin Lab Invest. 2007;67(3):306-16.</citation>
    <PMID>17454845</PMID>
  </reference>
  <reference>
    <citation>Ofstad AP, Gullestad L, Orvik E, Aakhus S, Endresen K, Ueland T, Aukrust P, Fagerland MW, Birkeland KI, Johansen OE. Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study. Cardiovasc Diabetol. 2013 Aug 30;12:126. doi: 10.1186/1475-2840-12-126.</citation>
    <PMID>23987834</PMID>
  </reference>
  <results_reference>
    <citation>Johansen OE, Gullestad L, Blaasaas KG, Orvik E, Birkeland KI. Effects of structured hospital-based care compared with standard care for Type 2 diabetes-The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial. Diabet Med. 2007 Sep;24(9):1019-27. Epub 2007 May 17.</citation>
    <PMID>17509068</PMID>
  </results_reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2005</study_first_submitted>
  <study_first_submitted_qc>August 23, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2005</study_first_posted>
  <last_update_submitted>January 23, 2017</last_update_submitted>
  <last_update_submitted_qc>January 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asker &amp; Baerum Hospital</investigator_affiliation>
    <investigator_full_name>Odd Erik Johansen</investigator_full_name>
    <investigator_title>Study director</investigator_title>
  </responsible_party>
  <keyword>Type 2 diabetes mellitus</keyword>
  <keyword>Cardiovascular</keyword>
  <keyword>Coronary artery disease</keyword>
  <keyword>Glycemic control</keyword>
  <keyword>Treatment</keyword>
  <keyword>Diabetes Mellitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

